dc.contributor | MARULANDA MEJIA, FELIPE | |
dc.contributor | Gonzalez-Correa, Clara Helena | |
dc.contributor | Duque Daniela | |
dc.contributor | Rojas Mariana | |
dc.contributor | Uribe Bernardo | |
dc.contributor | Ibarra Juan Camilo | |
dc.contributor | Morcillo Andrés | |
dc.contributor | Grupo de Investigación en Gerontología y Geriatría (Categoría A1) | |
dc.creator | Morcillo Muñoz, Jorge Alfredo | |
dc.date | 2022-05-02T17:37:11Z | |
dc.date | 2022-05-02T17:37:11Z | |
dc.date | 2022-04-30 | |
dc.date.accessioned | 2023-09-06T18:25:01Z | |
dc.date.available | 2023-09-06T18:25:01Z | |
dc.identifier | https://repositorio.ucaldas.edu.co/handle/ucaldas/17581 | |
dc.identifier | Universidad de Caldas | |
dc.identifier | Repositorio de la Universidad de Caldas | |
dc.identifier | https://repositorio.ucaldas.edu.co | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8696995 | |
dc.description | spa: Antecedentes y objetivos
El Ataque cerebrovascular (ACV) presenta alta carga de morbilidad asociada. La sarcopenia tiene relevancia como factor asociado a peores desenlaces en distintas patologías. El objetivo de este estudio fue establecer el impacto de la sarcopenia en desenlaces de importancia en una cohorte de pacientes con ACV isquémico.
Material y métodos
Se realizó un estudio observacional de cohorte prospectiva de pacientes > 45 años de edad con diagnóstico reciente de ACV en la ciudad de Manizales. La evaluación fue domiciliaria a la inclusión del estudio y después de 3 meses.
Se evaluó la presencia de sarcopenia utilizando dinamometría, y se evaluaron desenlaces clínicos, funcionales y grado de dependencia.
Resultados
Se incluyeron 28 pacientes con ACV, con edad promedio de 68,5 años, el 42,8% tenían sarcopenia, los pacientes con sarcopenia presentaron de forma estadísticamente significativa menor fuerza en el lado sano, menor circunferencia braquial y de pantorrilla bilateral y menor masa muscular esquelética, estos pacientes tenían una tendencia a presentar mayor discapacidad, dependencia y baja masa muscular después de 3 meses.
Conclusiones
Este es el primer estudio que describe, caracteriza y evalúa a los pacientes con ACV en función de la presencia de sarcopenia y sus desenlaces clínicos en Colombia. Los pacientes con ACV isquémico y sarcopenia tienen peores desenlaces clínicos, menor fuerza, así como una tendencia a mayor riesgo de discapacidad, dependencia y baja masa muscular en el seguimiento después de 3 meses. Lo que pone de manifiesto la evaluación de la sarcopenia de forma rutinaria en los pacientes con ACV. | |
dc.description | eng: Background and objectives
Stroke has a high burden of associated morbidity. Sarcopenia is a relevant factor in worses outcomes in different pathologies. The objective of this study was to establish the impact of sarcopenia on important outcomes in a cohort of patients with ischemic stroke.
Material and methods
An observational prospective cohort study of 45 years old patients with a recent diagnosis of stroke was conducted. The evaluation was done at home at the inclusion of the study and 3 months after.
The presence of sarcopenia was evaluated using dynamometry, clinical and functional outcomes and degree of dependence were evaluated.
Results
Twenty-eight stroke patients were included, with a mean age of 68.5 years, 42.8% had sarcopenia, patients with sarcopenia had statistically significantly lower strength on the healthy body side, lower bilateral brachial and calf circumference, and lower mass. Skeletal muscle, these patients have a tendency to present greater disability, dependency and low muscle mass 3 months after.
Conclusions
This is the first study that describes, characterizes and evaluates stroke patients based on the presence of sarcopenia and their clinical outcomes in Colombia. Patients with ischemic stroke and sarcopenia have worse clinical outcomes, lower strength, as well a tendency to
increased risk of disability, dependency, and low muscle mass at follow-up of 3 months after. This highlights the routine evaluation of sarcopenia in patients with stroke. | |
dc.description | Ilustraciones, gráficas | |
dc.description | Especialización médico - quirúrgica | |
dc.description | Especialista Medicina Interna | |
dc.description | Sarcopenia | |
dc.format | application/pdf | |
dc.format | application/pdf | |
dc.format | application/pdf | |
dc.format | application/pdf | |
dc.language | eng | |
dc.language | spa | |
dc.publisher | Facultad de Ciencias para la Salud | |
dc.publisher | Manizales | |
dc.publisher | Especialización Medicina Interna | |
dc.relation | 1. World health statistics 2019: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2019 | |
dc.relation | 2. Johnson W, Onuma O, Owalabi M, et al. Bulletin of the World Health Organization 2016;94:634-634ª | |
dc.relation | 3. De la Cruz R, Gaston L, Loterszpil M. 2016. Colombia Hacia un país de altos ingresos con movilidad social. Banco Interamericano de desarrollo. Colombia. | |
dc.relation | 4. Feigin VL, Roth GA, Naghavi M, et al. Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurol. 2016;15(9):913-924. | |
dc.relation | 5. Ouriques Martins SC, Sacks C, Hacke W, et al. Priorities to reduce the burden of stroke in Latin American Countries. Lancet Neurol. 2019;18(7):674-683 | |
dc.relation | 6. Bogousslavsky J LM, Moncayo J, Norrving B, et al. Stroke. Neurological disorders: public health challenges. Geneve: WHO Press; 2006. p. 151-63. | |
dc.relation | 7. Hankey GJ.Stroke. Lancet. 2017;389 (10069):641-654 | |
dc.relation | 8. Ekker MS, Boot EM, Singhal AB, et al. Epidemiology, aetiology, and management of ischaemic stroke in young adults. Lancet Neurol. 2018;17(9):790-801. | |
dc.relation | 9. Muñoz M. Enfermedad Cerebrovascular. Acta Neurol. Colomb.2010;262: 205-37 | |
dc.relation | 10. Ministerio de Salud y Protección social. Guía de práctica clínica de diagnóstico, tratamiento y rehabilitación del episodio agudo del ataque cerebrovascular isquémico en población mayor de 18 años. Colombia | |
dc.relation | 11. Kudling P, Billinger S. Exercise-Induced Changes of the Upper Extremity in Chronic Stroke Survivors Top Stroke Rehabil. 2005 Winter;12(1):58-68 | |
dc.relation | 12. Ivey FM1 , Hafer-Macko CE, Macko RF .Exercise Rehabilitation After Stroke. NeuroRx. 2006;3(4):439-50. | |
dc.relation | 13. Severinsen K, Jakobsen JK, Overgaard K, et al. Normalized muscle strength, aerobic capacity, and walking performance in chronic stroke: a population-based study on the potential for endurance and resistance training. Arch Phys Med Rehabil. 2011;92(10):1663-8 | |
dc.relation | 14. Cruz-Jentoft A, Cuesta Triana F, Gómez-Cabrera, et al. La eclosión de la sarcopenia: Informe preliminar del Observatorio de la Sarcopenia de la Sociedad 47 Española de Geriatría y Gerontología. Revista Española de Geriatría y Gerontología 2011;46(2):100- 10.20 | |
dc.relation | 15. Yoo C, Kim J, Yang Y, et al. Bioelectrical impedance analysis for severe stroke patients with upper extremity hemiplegia. J. Phys. Ther. Sci. 28: 2708-2712, 2016 | |
dc.relation | 16. Pollock A, Baer G, Campbell P , et al. Physical rehabilitation approaches for the recovery of function and mobility following stroke. Cochrane Database Syst Rev. 2014;(4):CD001920 | |
dc.relation | 17. Carga de enfermedad por enfermedades crónicas no transmisibles y discapacidad en Colombia. Informe técnico OMS V edición. 2015. | |
dc.relation | 18. Gutiérrez W, Martínez F, Olaya L. Sarcopenia, una patología nueva que impacta a la vejez. Revista Colombiana de Endocrinología, Diabetes y Metabolismo. 2018; 5(1): 28-36 | |
dc.relation | 19. Scherbakov N, Sandek A, Doehner W. Stroke-Related Sarcopenia: Specific Characteristics. J Am Med Dir Assoc. 2015;16(4):272-6 | |
dc.relation | 20. Park S, Ham JO, Lee BK. A positive association between stroke risk and sarcopenia in men aged ≥ 50 years, but not women: results from the Korean National Health and Nutrition Examination Survey 2008-2010. J Nutr Health Aging. 2014;18(9):806-12. | |
dc.relation | 21. Heredia Y, Impagliazzo L, Messina D y cols. Prevalencia de sarcopenia en pacientes internados en una clínica de rehabilitación en la provincia de Mendoza: resultados preliminares. 2018 | |
dc.relation | 22. Bae JH, Kang SH, Seo KM, et al. Relationship Between Grip and Pinch Strength and Activities of Daily Living in Stroke Patients Ann Rehabil Med 2015;39(5):752-762 | |
dc.relation | 23. Vidarte J, Castiblanco H, Gonzalez C, y Marulanda F. Efectos de un programa de intervención funcional sobre la fuerza en ancianos sarcopénicos (Colombia) Revista Latinoamericana de Hipertensión. 2018; 13: 169-174 | |
dc.relation | 24. Cruz-Jentoft A. J., Bahat G., Bauer J., et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing. 2019;48(1):16–31 | |
dc.relation | 25. Powers WJ, Rabinstein AA, Ackerson T, , et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018;49(3): e46-e110 | |
dc.relation | 26. Morotti A, Poli L, Costa P . Acute Stroke. Semin Neurol. 2019;39(1):61-72 | |
dc.relation | 27. Kunst MM, Schaefer PW. Ischemic stroke. Radiol Clin North Am. 2011 Jan;49(1):1-26 | |
dc.relation | 28. Chalem., Escandon., Campos., Esguerra. (2005). Tratado de Medicina Interna. Bogotá, Colombia. Editorial Celsus | |
dc.relation | 29. Pinilla Roa A. Compendio de terapéutica. Sexta edición. Bogotá, Colombia. Editorial Celsus. 2016 | |
dc.relation | 30. Scherbakov N, von Haehling S, Anker SD, et al. Stroke induced Sarcopenia: Muscle wasting and disability after stroke. International Journal of Cardiology 170 (2013) 89–94 | |
dc.relation | 31. Shaw SC, Denison EM, y Cooper C. Epidemiology of Sarcopenia: Determinants Throughout the Lifecourse Nat Rev Rheumatol. 2017; 13(6): 340–347. | |
dc.relation | 32. Olson R. Irwin H. Rosenberg Appointed Editor of Nutrition Reviews. Nutrition Reviews. 1998;46 309-310 | |
dc.relation | 33. Irwin H. Rosenberg, sarcopenia: origins and clinical relevance. Clinics geriatrics medicine. 2011; 27, 2011: 337-339. | |
dc.relation | 34. Rosenberg IH. Summary comments. Am J Clin Nutr 1989;50(Suppl):1231S–3S. | |
dc.relation | 35. Shock NW. Age changes in some physiologic processes. Geriatrics 1957;12:40–8. | |
dc.relation | 36. Nemerovsky J. Sarcopenia. Revista Argentina de Gerontología y Geriatría. 2016;30: 28-33 | |
dc.relation | 37. Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on Sarcopenia in Older People. Age Ageing. 2010 Jul;39(4):412-23. | |
dc.relation | 38. Carbajal Azcona. Composición corporal. Manual de Nutrición y Dietética. Universidad Complutense de Madrid [Internet]. 2013 [citado 201 Ago 13]. | |
dc.relation | 39. Wang ZM, Pierson RN, Heymsfield SB. The five level method: a new approach to organizing body---composition research. Am J Clin Nutr. 1992;56:19---28 | |
dc.relation | 40. Gonzalez E. Composición corporal: estudio y utilidad clínica. Endocrinol Nutr. 2013;60(2):69---75 | |
dc.relation | 41. WHO. Programme of nutrition, family and reproductive health. Obesity. Preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva, 3/5 June, 1997 | |
dc.relation | 42. Quesada L, León CC, Betancourt J y Nicolau Elizabet. Elementos teóricos y prácticos sobre la bioimpedancia eléctrica en salud. Rev. Arch Med Camagüey. 2016; 20(5): 565-578 | |
dc.relation | 43. Scherbakov N, Doehner W. Do we need a reference standard for the muscle mass measurements? ESC Heart Failure 2018; 5: 741–744 | |
dc.relation | 44. De Deyne PG, Hafer-Macko CE, Ivey FM. Muscle molecular phenotype after stroke is associated with gait speed. Muscle Nerve. 2004 ;30(2):209-15. | |
dc.relation | 45. Scherbakov N, Charlotte Pietrock C, Anja Sandek A. Body weight changes and incidence of cachexia after Stroke.Journal of Cachexia, Sarcopenia and Muscle 2019; 10: 611–620 | |
dc.relation | 46. Scherbakov N, Doehner W. Sarcopenia in stroke-facts and numbers on muscle loss accounting for disability after stroke. J Cachexia Sarcopenia Muscle. 2011;2(1):5–8 | |
dc.relation | 47. de Souza Barbosa JF, Zepeda MU, Béland F, Guralnik JM, Zunzunegui MV, Guerra RO. Clinically relevant weakness in diverse populations of older adults participating in the International Mobility in Aging Study. Age (Dordr). 2016;38(1):25. | |
dc.relation | 48. Villada-Gómez JS, González-Correa CH y Marulanda-Mejía F. Puntos de corte provisionales para el diagnóstico de sarcopenia en ancianos de Caldas, Colombia. Biomédica. 2018; 38(4), 521-526. | |
dc.relation | 49. Su Y, Yuki M, Otsuki M. Prevalence of stroke-related sarcopenia: A systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2020;29(9):105092. | |
dc.relation | 50. Liu G, Xue Y, Wang S, Zhang Y, Geng Q. Association between hand grip strength and stroke in China: a prospective cohort study. Aging (Albany NY). 2021 Mar 3;13(6):8204-8213 | |
dc.relation | 51. Nozoe M, Kanai M, Kubo H, Yamamoto M, Shimada S, Mase K. Prestroke sarcopenia and functional outcomes in elderly patients who have had an acute stroke: A prospective cohort study. Nutrition. 2019;66:44-47 | |
dc.relation | 52. Shiraishi A, Yoshimura Y, Wakabayashi H, Tsuji Y. Prevalence of stroke-related sarcopenia and its association with poor oral status in post-acute stroke patients: Implications for oral sarcopenia. Clin Nutr. 2018;37(1):204-207. | |
dc.relation | 53. Park JG, Lee KW, Kim SB, Lee JH, Kim YH. Effect of Decreased Skeletal Muscle Index and Hand Grip Strength on Functional Recovery in Subacute Ambulatory Stroke Patients. Ann Rehabil Med. 2019;43(5):535-543. | |
dc.relation | 54. Yi Y, Shim JS, Oh BM, Seo HG. Grip Strength on the Unaffected Side as an Independent Predictor of Functional Improvement After Stroke. Am J Phys Med Rehabil. 2017 Sep;96(9):616-620 | |
dc.relation | 55. Bae JH, Kang SH, Seo KM, Kim DK, Shin HI, Shin HE. Relationship Between Grip and Pinch Strength and Activities of Daily Living in Stroke Patients. Ann Rehabil Med. 2015 oct;39(5):752-62.2 | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.rights | http://purl.org/coar/access_right/c_14cb | |
dc.subject | Enfermedades | |
dc.subject | Infartos | |
dc.subject | Cerebro | |
dc.subject | Sarcopenia | |
dc.subject | Accidente cerebrovascular | |
dc.subject | Dinamometría manual | |
dc.subject | Estado funcional | |
dc.subject | Fuerza de la mano | |
dc.subject | Impedancia eléctrica | |
dc.subject | Stroke | |
dc.title | Impacto de la sarcopenia en los desenlaces clínicos, funcionales y grado de dependencia en una cohorte de pacientes con ataque cerebrovascular isquémico | |
dc.type | Trabajo de grado - Especialización | |
dc.type | http://purl.org/coar/resource_type/c_7a1f | |
dc.type | Text | |
dc.type | info:eu-repo/semantics/bachelorThesis | |
dc.type | https://purl.org/redcol/resource_type/TP | |
dc.type | info:eu-repo/semantics/publishedVersion | |